Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2016-02-28 Earnings Release
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
2015年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '2015 年度业绩快报' which translates to '2015 Annual Performance Express Report' or '2015 Annual Earnings Quick Report'. It contains preliminary financial data for the year 2015, including revenue, profit, net income, earnings per share, and asset information. The document explicitly states that the data is preliminary, internally audited but not audited by an external accounting firm, and may differ from the final annual report. It also includes explanations of financial performance and changes compared to the previous year. The document length is 1427 characters, which is quite short and more consistent with a brief earnings release or performance summary rather than a full annual report. There is no indication that this is a full Annual Report (10-K) or a detailed Management Discussion & Analysis (MDA). It is not an announcement of a report publication but the actual preliminary financial data. Therefore, the best fit is Earnings Release (ER), which is the initial announcement of yearly financial results with key highlights only. FY 2015
2016-02-28 Chinese
关于收到中国证监会行政许可申请中止审查通知书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the receipt of a notice from the China Securities Regulatory Commission (CSRC) about the suspension of review of their non-public stock issuance application. It details procedural updates, regulatory interactions, and future intentions related to the stock issuance process. The document is short (1005 characters) and primarily serves as a regulatory update rather than containing financial statements or detailed financial data. It does not present financial results, audit opinions, or management discussions. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2016-02-23 Chinese
2016年第二次临时股东大会决议的公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2016 second extraordinary general meeting (临时股东大会) of Shandong Ruikang Pharmaceutical Co., Ltd. It includes voting results on various proposals related to a non-public issuance of A shares, details of the meeting attendance, voting percentages, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on shareholder meeting decisions and voting outcomes rather than the full report or financial statements. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is over 5,000 characters and contains substantive voting data, not just a brief announcement or a link to a report, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is DVA with high confidence.
2016-02-16 Chinese
2016年第二次临时股东大会的律师见证法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2016 second extraordinary general meeting (临时股东大会) of Shandong Ruikang Pharmaceutical Co., Ltd. It details the convening, attendance, agenda, voting procedures, and results of the shareholders' meeting. The document includes legal verification of the meeting's compliance with relevant laws and company articles. It is not a financial report, earnings release, or management discussion, but a legal certification related to a shareholders' meeting. The content focuses on the voting results and legal opinion on the meeting's validity, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (7057 characters) and detailed voting results support this classification rather than a brief announcement or a full annual report.
2016-02-16 Chinese
关于实际控制人进行股票质押式回购交易的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding a stock pledge transaction by the company's actual controller. It details the number of shares pledged, the pledgee bank, and the pledge period. There is no financial report, earnings data, or management discussion. The content fits the category of a transaction involving shares by a major shareholder or insider. It is not a full report, earnings release, or regulatory certification. The closest specific category is 'Major Shareholding Notification' (MRQ), as it involves disclosure of significant share pledging by a major shareholder.
2016-02-05 Chinese
第二届董事会第三十三次会议决议的公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board of directors meeting of Shandong Ruikang Pharmaceutical Co., Ltd. It includes voting results on various proposals related to a non-public issuance of A shares, adjustments to the issuance plan, related party transactions, authorization for the board to handle issuance matters, and scheduling of an extraordinary shareholders meeting. The content focuses on board decisions and approvals rather than financial results or report publication. It is not a full financial report, earnings release, or regulatory filing of a different nature. The document is a formal announcement of board meeting resolutions, which fits the category of Board/Management Information (MANG). The document length (6894 characters) and detailed voting results support this classification rather than a brief announcement or a report publication announcement.
2016-01-31 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.